Cancer Treatment with Nanoparticles: An overview
Keywords:
Cancer, Personalized medicine, therapeutic outcome, tumor.Abstract
One of the greatest global causes of death is cancer. Chemotherapy, radiation therapy, and immunotherapy are all forms of cancer treatment, but they all have a number of drawbacks, including cytotoxicity, drug resistance, and other restrictions. The surface properties, ideal size, and shape of nanoparticles have revolutionised cancer treatment by enhancing biodistribution, pharmacokinetics, and biocompatibility. Additionally, the delivery of bioactive plant-based anticancer medicines such as vinca alkaloids, taxanes, podophyllotoxin, and others has been improved using phytonanotechnology. Novel silver nanoparticles are also used as a delivery mechanism for anticancer medications. In this overview, we'll look at silver nanoparticles for drug delivery in cancer disorders, phytonanotechnology, and important uses of nanotechnology.
Keywords: Cancer, Conventional chemotherapy, Mechanism, Nanotechnology, Silver nanoparticles
Downloads
References
C.M. Pfeffer, A.T. Singh, Apoptosis: a target for anticancer therapy, International journal of molecular sciences 19(2) (2018) 448.
W. Ardelt, B. Ardelt, Z. Darzynkiewicz, Ribonucleases as potential modalities in anticancer therapy, European journal of pharmacology 625(1-3) (2009) 181-189.
J.A. Malik, M. Maqbool, COVID-19: An overview of current scenario, CELLMED 10(3) (2020) 21.1-21.8.
M. Maqbool, EVALUATION OF DRUG UTILIZATION PATTERN IN THE PEDIATRIC DEPARTMENT OF A TERTIARY CARE HOSPITAL IN SRINAGAR, JAMMU & KASHMIR, INDIA, Journal of Applied Pharmaceutical Sciences and Research (2019) 6-9.
C.-Y. Zhao, R. Cheng, Z. Yang, Z.-M. Tian, Nanotechnology for cancer therapy based on chemotherapy, Molecules 23(4) (2018) 826.
M. Coccia, L. Wang, Path-breaking directions of nanotechnology-based chemotherapy and molecular cancer therapy, Technological Forecasting and Social Change 94 (2015) 155-169.
M. Maqbool, M.A. Dar, I. Gani, S.A. Mir, M. Khan, Herbal medicines as an alternative source of therapy: a review, World J Pharm Pharm Sci 3 (2019) 374-80.
S. Rasool, M. Maqbool, An overview about Hedychium spicatum: a review, Journal of Drug Delivery and Therapeutics 9(1-s) (2019) 476-480.
X.-J. Liang, C. Chen, Y. Zhao, P.C. Wang, Circumventing tumor resistance to chemotherapy by nanotechnology, Multi-drug resistance in cancer (2010) 467-488.
Y. Sun, W. Ma, Y. Yang, M. He, A. Li, L. Bai, B. Yu, Z. Yu, Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy, Asian journal of pharmaceutical sciences 14(6) (2019) 581-594.
M. Maqbool, M. Khan, M. Mohammad, M.A. Adesina, G. Fekadu, Awareness about reproductive health in adolescents and youth: a review, Journal of Applied Pharmaceutical Sciences and Research (2019) 1-5.
K. Lavudi, R.R. Kokkanti, G. Harika, S. Patnaik, J. Penchalaneni, Chemotherapeutic potential of AgNP orchestrated Semecarpus anacardium nut extracts against Ovarian cancer cell line, PA-1, (2022).
D. Liu, X. Dai, L. Ye, H. Wang, H. Qian, H. Cheng, X. Wang, Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 15(1) (2023) e1838.
D. Kovács, K. Szőke, N. Igaz, G. Spengler, J. Molnár, T. Tóth, D. Madarász, Z. Rázga, Z. Kónya, I.M. Boros, Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer, Nanomedicine: Nanotechnology, Biology and Medicine 12(3) (2016) 601-610.
I. Ara, M. Maqbool, G. Fekadu, T.A. Hajam, M.A. Dar, Pharmaceutical significance of Nigella sativa L., a wonder herb, Journal of Applied Pharmaceutical Sciences and Research 3(4) (2020) 04-13.
I. Ara, M. Maqbool, I. Gani, Neuroprotective Activity of Herbal Medicinal Products: A Review, International Journal of Current Research in Physiology and Pharmacology (2022) 1-10.
M. Ramezani, M. Ebrahimian, M. Hashemi, Current strategies in the modification of PLGA-based gene delivery system, Current medicinal chemistry 24(7) (2017) 728-739.
M. Zehravi, M. Maqbool, I. Ara, Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review, Open Health 3(1) (2022) 60-65.
F.S. Tabatabaei Mirakabad, K. Nejati-Koshki, A. Akbarzadeh, M.R. Yamchi, M. Milani, N. Zarghami, V. Zeighamian, A. Rahimzadeh, S. Alimohammadi, Y. Hanifehpour, PLGA-based nanoparticles as cancer drug delivery systems, Asian Pacific Journal of Cancer Prevention 15(2) (2014) 517-535.
M. Alvi, A. Yaqoob, K. Rehman, S.M. Shoaib, M.S.H. Akash, PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives, AAPS Open 8(1) (2022) 1-17.
I. Ara, M. Maqbool, M. Zehravi, Psychic consequences of infertility on couples: A short commentary, Open Health 3(1) (2022) 114-119.
S. Li, X. Li, J. Ding, L. Han, X. Guo, Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer, Drug Design, Development and Therapy (2019) 1271-1280.
I. Ara, M. Maqbool, I. Gani, Reproductive Health of Women: Implications and attributes, International Journal of Current Research in Physiology and Pharmacology (2022) 8-18.
M.A. Dar, I. Gani, I. Ara, Overview of substance use disorders and available treatments, Int. J. Curr. Res. Physiol. Pharmacol 7(2) (2023) 3-7.
M. Ullmann, S.K. Friedlander, A. Schmidt-Ott, Nanoparticle formation by laser ablation, Journal of Nanoparticle Research 4 (2002) 499-509.
A. Majeed, R. Bashir, S. Farooq, M. Maqbool, Preparation, characterization and applications of nanoemulsions: An insight, Journal of Drug Delivery and Therapeutics 9(2) (2019) 520-527.
C. Phipps, Laser ablation and its applications, Springer2007.
M. Maqbool, D. Dugassa, G. Fekadu, Adverse Drug Reactions of Antiepileptic Drugs in the Neurology Department of a Tertiary Care Hospital, Srinagar, Jammu & Kashmir, India, Archives of Neuroscience 8(2) (2021).
N. Semaltianos, Nanoparticles by laser ablation, Critical reviews in solid state and materials sciences 35(2) (2010) 105-124.
M. Mohd, M. Maqbool, M.A. Dar, I. Mushtaq, Polycystic ovary syndrome, a modern epidemic: an overview, Journal of Drug Delivery and Therapeutics 9(3) (2019) 641-644.
N. Pantidos, L.E. Horsfall, Biological synthesis of metallic nanoparticles by bacteria, fungi and plants, Journal of Nanomedicine & Nanotechnology 5(5) (2014) 1.
M. Zehravi, M. Maqbool, I. Ara, Correlation between obesity, gestational diabetes mellitus, and pregnancy outcomes: an overview, International Journal of Adolescent Medicine and Health 33(6) (2021) 339-345.
R. Maqbool, M. Maqbool, M. Zehravi, I. Ara, Menstrual distress in females of reproductive age: a literature review, International journal of adolescent medicine and health 34(2) (2021) 11-17.
K. Gudikandula, S. Charya Maringanti, Synthesis of silver nanoparticles by chemical and biological methods and their antimicrobial properties, Journal of experimental nanoscience 11(9) (2016) 714-721.
S. Iravani, H. Korbekandi, S.V. Mirmohammadi, B. Zolfaghari, Synthesis of silver nanoparticles: chemical, physical and biological methods, Research in pharmaceutical sciences 9(6) (2014) 385.
H.R. Ghorbani, A.A. Safekordi, H. Attar, S. Sorkhabadi, Biological and non-biological methods for silver nanoparticles synthesis, Chemical and Biochemical Engineering Quarterly 25(3) (2011) 317-326.
M. Maqbool, S. Rasool, M.A. Dar, R. Bashir, M. Khan, Hepatotoxicity and Hepatoprotective agents: A Mini review, PharmaTutor 7(9) (2019) 34-40.
M. Maqbool, M.A. Dar, I. Gani, S.A. Mir, M. Khan, A.U. Bhat, Maternal health and nutrition in pregnancy: an insight, World Journal of Pharmacy and Pharmaceutical Sciences 8(3) (2019) 450-459.
A.K. Mittal, Y. Chisti, U.C. Banerjee, Synthesis of metallic nanoparticles using plant extracts, Biotechnology advances 31(2) (2013) 346-356.
M. Maqbool, G. Fekadu, X. Jiang, F. Bekele, T. Tolossa, E. Turi, G. Fetensa, K. Fanta, An up to date on clinical prospects and management of osteoarthritis, Annals of Medicine and Surgery 72 (2021) 103077.
M. Zehravi, M. Maqbool, I. Ara, Depression and anxiety in women with polycystic ovarian syndrome: a literature survey, International Journal of Adolescent Medicine and Health 33(6) (2021) 367-373.
H.-J. Lee, G. Lee, N.R. Jang, J.H. Yun, J.Y. Song, B.S. Kim, Biological synthesis of copper nanoparticles using plant extract, Nanotechnology 1(1) (2011) 371-374.
I. Ara, M. Maqbool, B. Bukhari, N. Ara, T.A. Hajam, Present status, standardization and safety issues with herbal drugs, International Journal of Research in Pharmaceutical Sciences and Technology 1(3) (2020) 95-101.
M. Maqbool, G. Fekadu, D. Dugassa, F. Bekele, E. Turi, D. Simegnew, The pattern of substance abuse in the psychiatry department of a tertiary care of Srinagar hospital, Jammu and Kashmir, India, Archives of Neuroscience 7(4) (2020).
R.H. Staff, K. Landfester, D. Crespy, Recent advances in the emulsion solvent evaporation technique for the preparation of nanoparticles and nanocapsules, Hierarchical Macromolecular Structures: 60 Years after the Staudinger Nobel Prize II (2013) 329-344.
M. Maqbool, A.M. Dar, S. Rasool, M. Khan, Curious case of drug resistant malaria and artemisinin compounds in the modern era, Journal of Applied Pharmaceutical Sciences and Research (2019) 1-4.
G. Fekadu, F. Bekele, K. Bekele, S. Hanbisa, G. Belay, M. Maqbool, Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia, Cardiovascular Therapeutics 2020 (2020).
M. G Nava-Arzaluz, E. Piñón-Segundo, A. Ganem-Rondero, D. Lechuga-Ballesteros, Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles, Recent patents on drug delivery & formulation 6(3) (2012) 209-223.
M. Maqbool, N. Nasir, S. Mustafa, Polycystic in ovarian syndrome and its various treatment strategies, INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 5(9) (2018) 8470-8478.
N.T. Chi, N.M. Triet, D.M. Chien, Preparation of drug nanoparticles by emulsion evaporation method, Journal of Physics: conference series, IOP Publishing, 2009, p. 012047.
M. Maqbool, M. Dar, S. Rasool, S. Mir, A. Bhat, M. Khan, Clinical pharmacy practice in health care system: A review, Eur J Pharm Med Res 6(4) (2019) 630-633.
R.H. Staff, D. Schaeffel, A. Turshatov, D. Donadio, H.J. Butt, K. Landfester, K. Koynov, D. Crespy, Particle Formation in the Emulsion‐Solvent Evaporation Process, Small 9(20) (2013) 3514-3522.
M. Maqbool, A. Naeem, S. Aamer, Diabetes Mellitus and Its Various Management Strategies in Practice, Indo American Journal of Pharmaceutical Sciences 5(8) (2018) 8163-+.
S. Chatterjee, F. Salaün, C. Campagne, S. Vaupre, A. Beirão, A. El-Achari, Synthesis and characterization of chitosan droplet particles by ionic gelation and phase coacervation, Polymer bulletin 71 (2014) 1001-1013.
S.K. Basu, K. Kavitha, M. Rupeshkumar, Evaluation of ketorolac tromethamine microspheres by chitosan/gelatin B complex coacervation, Scientia pharmaceutica 78(1) (2010) 79-92.
D.J. Burgess, Complex coacervation: microcapsule formation, Macromolecular complexes in chemistry and biology (1994) 285-300.
D. Burgess, J. Carless, Manufacture of gelatin/gelatin coacervate microcapsules, International journal of pharmaceutics 27(1) (1985) 61-70.
M. Maqbool, S. Tariq, S. Amjad, Prescribing Practices in Pediatrics and Drug Utilization Studies Promoting Pediatric Health, Indo American Journal of Pharmaceutical Sciences 5(8) (2018) 8070-8076.
M.A. Dar, M. Maqbool, S. Rasool, Pharmaceutical wastes and their disposal practice in routine, Int J Inf Comput Sci 6 (2019) 76-92.
C. Fang, M. Zhang, Multifunctional magnetic nanoparticles for medical imaging applications, Journal of materials chemistry 19(35) (2009) 6258-6266.
W.-Y. Huang, J.J. Davis, Multimodality and nanoparticles in medical imaging, Dalton Transactions 40(23) (2011) 6087-6103.
A. Banstola, F. Emami, J.-H. Jeong, S. Yook, Current applications of gold nanoparticles for medical imaging and as treatment agents for managing pancreatic cancer, Macromolecular Research 26 (2018) 955-964.
S. Rasool, M. Maqbool, Y. Joshi, Drug utilization studies among ENT patients in various clinical settings: A comprehensive review, Journal of Drug Delivery and Therapeutics 9(1-s) (2019) 481-485.
D.P. Cormode, P.A. Jarzyna, W.J. Mulder, Z.A. Fayad, Modified natural nanoparticles as contrast agents for medical imaging, Advanced drug delivery reviews 62(3) (2010) 329-338.
L. Larush, S. Magdassi, Formation of near-infrared fluorescent nanoparticles for medical imaging, Nanomedicine 6(2) (2011) 233-240.
M. Maqbool, M.A. Dar, S. Rasool, I. Gani, M. Khan, Substance use disorder and availability of treatment options: an overview, Journal of research in health science 1 (2019) 4-10.
M. Maqbool, S. Javed, A.A. Bajwa, Assessment OF pain management IN postoperative cases using different scales and questionnaires, INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 6(1) (2019) 983-987.
H. Li, H. Jin, W. Wan, C. Wu, L. Wei, Cancer nanomedicine: mechanisms, obstacles and strategies, Nanomedicine 13(13) (2018) 1639-1656.
M. Maqbool, B. Arshad, S. Liaquat, PSYCHOTROPIC DRUG UTILISATION PATTERN CAN BE USEFUL IN MONITORING TREATMENT REGIMENS FOR MENTAL DISORDERS IN PSYCHIATRIC SETTINGS, INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 5(8) (2018) 7717-7721.
M. Maqbool, I. Gani, Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review, Journal of Pharmacy Practice and Community Medicine 4(4) (2018).
L. Cohen, Y.D. Livney, Y.G. Assaraf, Targeted nanomedicine modalities for prostate cancer treatment, Drug Resistance Updates 56 (2021) 100762.
M. Maqbool, M. Zehravi, R. Maqbool, I. Ara, An Overview about Treatment of Gestational Diabetes Mellitus: A Short Communication, CELLMED 11(3) (2021) 12.1-12.5.
R. Bazak, M. Houri, S. El Achy, S. Kamel, T. Refaat, Cancer active targeting by nanoparticles: a comprehensive review of literature, Journal of cancer research and clinical oncology 141 (2015) 769-784.
Z.R. Goddard, M.J. Marín, D.A. Russell, M. Searcey, Active targeting of gold nanoparticles as cancer therapeutics, Chemical Society Reviews 49(23) (2020) 8774-8789.
R. Bashir, M. Maqbool, I. Ara, M. Zehravi, An In sight into Novel Drug Delivery System: In Situ Gels, CELLMED 11(1) (2021) 6.1-6.7.
J.D. Byrne, T. Betancourt, L. Brannon-Peppas, Active targeting schemes for nanoparticle systems in cancer therapeutics, Advanced drug delivery reviews 60(15) (2008) 1615-1626.
C.H.J. Choi, C.A. Alabi, P. Webster, M.E. Davis, Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles, Proceedings of the National Academy of Sciences 107(3) (2010) 1235-1240.
A. Ahmad, F. Khan, R.K. Mishra, R. Khan, Precision cancer nanotherapy: evolving role of multifunctional nanoparticles for cancer active targeting, Journal of medicinal chemistry 62(23) (2019) 10475-10496.
G. Fekadu, B. Gamachu, T. Mengie, M. Maqbool, Knowledge, attitude of health care professional’s towards clinical pharmacy services in Nedjo General Hospital, Western Ethiopia, International Journal 5(7) (2019) 172.
S.A. Bhat, S.A. Mir, M. Maqbool, A.U. Bhat, M.H. Masoodi, Evaluation of phytochemical, antioxidant, and in-vitro antidiarrhoeal, activity of Euphorbia hirta, Journal of Drug Delivery and Therapeutics 9(1-s) (2019) 290-294.
M. Maqbool, M. Zehravi, Neuroprotective Role of Polyphenols in Treatment of Neurological Disorders: A Review, Interventional Pain Medicine and Neuromodulation 1(1) (2021).
I. Ara, M. Maqbool, The curious case of Neuropathic Pain and its management: an overview, Open Health 3(1) (2022) 145-154.
R. Bazak, M. Houri, S. El Achy, W. Hussein, T. Refaat, Passive targeting of nanoparticles to cancer: A comprehensive review of the literature, Molecular and clinical oncology 2(6) (2014) 904-908.
I. Ara, M. Zehravi, M. Maqbool, I. Gani, A Review of Recent Developments and Future Challenges in the Implementation of Universal Health Coverage Policy Framework in Some Countries, Journal of Pharmaceutical Research & Reports. SRC/JPRSR-131. DOI: doi. org/10.47363/JPRSR/2022 (3) 127 (2022).
M. Zehravi, R. Maqbool, M. Maqbool, I. Ara, To Identify Patterns of Drug Usage among Patients Who Seek Care in Psychiatry Outpatient Department of a Tertiary Care Hospital in Srinagar, Jammu and Kashmir, India, Journal of Pharmaceutical Research International 33(31A) (2021) 135-140.
M.F. Attia, N. Anton, J. Wallyn, Z. Omran, T.F. Vandamme, An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites, Journal of Pharmacy and Pharmacology 71(8) (2019) 1185-1198.
I. Ara, M. Maqbool, M. Zehravi, I. Gani, Herbs Boosting Immunity in Covid-19: An Overview, Adv J Chem B 3(3) (2020) 289-94.
J.A. Malik, M. Maqbool, T.A. Hajam, M.A. Khan, M. Zehravi, Comparison of different classes of drugs for Management of Acute Coronary Syndrome (ACS): A brief communication, CELLMED 11(2) (2021) 7.1-7.5.
T.D. Clemons, R. Singh, A. Sorolla, N. Chaudhari, A. Hubbard, K.S. Iyer, Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy, Langmuir 34(50) (2018) 15343-15349.
M. Maqbool, M. Khan, Hypertension and Pregnancy: an important issue, PharmaTutor 7(8) (2019) 71-78.
M.A. Dar, M. Maqbool, S. Javed, Assessing Health-Related Quality Of Life (Qol) In Rheumatoid Arthritis, INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 6(1) (2019) 988-994.
M. Maqbool, W. Shabbir, S. Aamir, Adverse Events Of Blood Transfusion And Blood Safety In Clinical Practice, Indo American Journal Of Pharmaceutical Sciences 5(8) (2018) 8254-8259.
J. Ye, Q. Wang, X. Zhou, N. Zhang, Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis, International journal of pharmaceutics 352(1-2) (2008) 273-279.
A.A. Sebak, B.M. El-Shenawy, S. El-Safy, M. El-Shazly, From passive targeting to personalized nanomedicine: multidimensional insights on nanoparticles’ interaction with the tumor microenvironment, Current Pharmaceutical Biotechnology 22(11) (2021) 1444-1465.
G. Su, H. Jiang, B. Xu, Y. Yu, X. Chen, Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized PEGylation nanoparticles, Molecular Pharmaceutics 15(11) (2018) 5019-5030.
M. Zehravi, M. Maqbool, I. Ara, Teenage menstrual dysfunction: an overview, International Journal of Adolescent Medicine and Health (2022).
M. Maqbool, M.A. Dar, S. Rasool, R. Bashir, M. Khan, Substance use Disorder: A Burning Issue, Lancet 375(9719) (2019) 1014-1028.
M. Zehravi, M. Maqbool, I. Ara, An Update on Pain Control in Conservative Dentistry and Endodontics: A Review, The Indian Journal of Nutrition and Dietetics (2022) 114-125.
V. Oliveri, Selective targeting of cancer cells by copper ionophores: an overview, Frontiers in molecular biosciences 9 (2022).
A. Gupte, R.J. Mumper, Elevated copper and oxidative stress in cancer cells as a target for cancer treatment, Cancer treatment reviews 35(1) (2009) 32-46.
C.V. Dang, M. Hamaker, P. Sun, A. Le, P. Gao, Therapeutic targeting of cancer cell metabolism, Journal of molecular medicine 89 (2011) 205-212.
M. Maqbool, U. Ikram, A. Anwar, Adverse Drug Reaction Monitoring And Occurrence In Drugs Used In Pulmonary Disorders, Indo American Journal Of Pharmaceutical Sciences 5(8) (2018) 8060-8065.
O.C. Farokhzad, S. Jon, A. Khademhosseini, T.-N.T. Tran, D.A. LaVan, R. Langer, Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells, Cancer research 64(21) (2004) 7668-7672.
I. Ara, M.A. Kalam, M. Maqbool, M. Zehravi, Phytochemical Standardization and Anti-Anxiety (Izterab-e-Nafsani) study of Aftimoon Hindi (Cuscuta reflexa Roxb.) on An Animal Model, CELLMED 11(3) (2021) 14.1-14.9.
M. Maqbool, M. Zehravi, R. Maqbool, I. Ara, Study of adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India, CELLMED 11(2) (2021) 8.1-8.5.
M. Shadidi, M. Sioud, Selective targeting of cancer cells using synthetic peptides, Drug Resistance Updates 6(6) (2003) 363-371.
M. Khan, M. Maqbool, Maternal Health: An important issue, Journal of research in health science (2019) 1-2.
A.H. Bong, G.R. Monteith, Calcium signaling and the therapeutic targeting of cancer cells, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1865(11) (2018) 1786-1794.
M.A. Dar, M. Maqbool, I. Gani, I. Ara, Menstruation hygiene and related issues in adolescent girls: A brief commentary, International Journal of Current Research in Physiology and Pharmacology (2023) 1-5.
M. Zehravi, M. Maqbool, I. Ara, An Overview about Safety Surveillance of Adverse Drug Reactions and Pharmacovigilance in India, The Indian Journal of Nutrition and Dietetics (2021) 408-418.
M. Carvalho, R. Reis, J.M. Oliveira, Dendrimer nanoparticles for colorectal cancer applications, Journal of Materials Chemistry B 8(6) (2020) 1128-1138.
I. Ara, M. Maqbool, I. Gani, Specificity and Personalized medicine: a novel approach to Cancer management, International Journal of Current Research in Physiology and Pharmacology (2022) 11-20.
S.P. Kambhampati, R.M. Kannan, Dendrimer nanoparticles for ocular drug delivery, Journal of Ocular Pharmacology and Therapeutics 29(2) (2013) 151-165.
D.J. Bharali, M. Khalil, M. Gurbuz, T.M. Simone, S.A. Mousa, Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers, International journal of nanomedicine (2009) 1-7.
T.P. Thomas, A.K. Patri, A. Myc, M.T. Myaing, J.Y. Ye, T.B. Norris, J.R. Baker, In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles, Biomacromolecules 5(6) (2004) 2269-2274.
R.A. Rayan, I. Zafar, H. Rajab, M.A.M. Zubair, M. Maqbool, S. Hussain, Impact of IoT in Biomedical Applications Using Machine and Deep Learning, Machine Learning Algorithms for Signal and Image Processing (2022) 339-360.
L.S. Pang, J.D. Saxby, S.P. Chatfield, Thermogravimetric analysis of carbon nanotubes and nanoparticles, The Journal of Physical Chemistry 97(27) (1993) 6941-6942.
M. Maqbool, I. Ara, I. Gani, The Story of Polycystic Ovarian Syndrome: A Challenging Disorder with Numerous Consequences for Females of Reproductive Age, International Journal of Current Research in Physiology and Pharmacology (2022) 19-31.
G.G. Wildgoose, C.E. Banks, R.G. Compton, Metal nanoparticles and related materials supported on carbon nanotubes: methods and applications, Small 2(2) (2006) 182-193.
M. Zehravi, M. Maqbool, I. Ara, Unfolding the mystery of premenstrual syndrome (PMS): an overview, International Journal of Adolescent Medicine and Health (2022).
P. Kumar, A. Robins, S. Vardoulakis, R. Britter, A review of the characteristics of nanoparticles in the urban atmosphere and the prospects for developing regulatory controls, Atmospheric Environment 44(39) (2010) 5035-5052.
X. Duan, Y. Li, Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking, Small 9(9‐10) (2013) 1521-1532.
V. Mohanraj, Y. Chen, Nanoparticles-a review, Tropical journal of pharmaceutical research 5(1) (2006) 561-573.
J.V. Georgieva, D. Kalicharan, P.-O. Couraud, I.A. Romero, B. Weksler, D. Hoekstra, I.S. Zuhorn, Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro, Molecular Therapy 19(2) (2011) 318-325.
M. Sajid, J. Płotka-Wasylka, Nanoparticles: Synthesis, characteristics, and applications in analytical and other sciences, Microchemical Journal 154 (2020) 104623.
S.W. See, R. Balasubramanian, U.M. Joshi, Physical characteristics of nanoparticles emitted from incense smoke, Science and Technology of Advanced Materials 8(1-2) (2007) 25.
A. Tomar, G. Garg, Short review on application of gold nanoparticles, Global Journal of Pharmacology 7(1) (2013) 34-38.
M.F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M. Alonso, P. Labrude, C. Vigneron, Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method, Journal of controlled release 50(1-3) (1998) 31-40.
K. Luyts, D. Napierska, B. Nemery, P.H. Hoet, How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations, Environmental science: processes & impacts 15(1) (2013) 23-38.
Published
Issue
Section
License
Copyright (c) 2023 Mohd Altaf Dar, Aslam Hamid Khan, Mashooq Ahmad Mir, Abrar Bashir Malik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
